Mirati Therapeutics Inc operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Mirati Therapeutics Inc with three other
companies in this sector in CANADA :
Liminal BioSciences Inc
sales of 4.90 million Canadian Dollars [US$3.72 million]
of which 97%
was Plasma derived therapeutics),
Pond Technologies Holdings Inc
(6.14 million Canadian Dollars [US$4.65 million]
of which 58%
was Nutraceutical Products), and
VBI Vaccines Inc
(2.94 million Canadian Dollars [US$2.23 million]
of which 76%
was R&D Service revenue).